Search Results 1921-1930 of 19669 for Hemoglobin

1. A Study to Evaluate GB002 in Adults with Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

   Hemoglobin (Hgb) concentration < 8.5 g/dL at screening. Evidence of active human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C, or tuberculosis ...

2. Publications - Abhinav Khanna, M.D. - Mayo Clinic

   Hemoglobin A1c improvements and better diabetes-specific quality of life among participants completing diabetes self-management programs: a nested cohort ...

3. Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) - Mayo Clinic

   Hemoglobin ≥ g/dL;; Absolute neutrophil count ≥000/μL;; Platelet count ≥5000/μL;; Total bilirubin (TBL) ≤.0× upper limit of normal (ULN);; AST and ALT ...

4. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

   ... hemoglobin; Meeting drug stabilization requirements, as applicable: Background mycophenolate, methotrexate, or azathioprine (no more than 1 therapy) for ≥ 6 ...

5. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

   or >480 pg/mL (if in atrial fibrillation or atrial flutter). 6. Body mass index (BMI) ≥18 kg/m2 and ≤45 kg/m2 7. Screening hemoglobin ≥9.0 g/dL ...

6. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL. Note: Transfusions will be allowed to achieve this. Transfusions will be permitted provided the patient has not received more than 2 ...

7. Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL;; Total bilirubin ≤ 1.5 x the upper limit of the normal range (ULN);; Aspartate aminotransferase (AST) ≤ 3 x ULN;; Alanine ...

8. FrαDcs Or Placebo For Patients With Advanced Stage Ovarian Cancer - Mayo Clinic

   Participation eligibility · Hemoglobin ≥ 8.5 g/dL; · Absolute neutrophil count (ANC) ≥ 1000/mm3; · Platelet count ≥ 75,000/mm3; · Lymphocytes ≥ 0.3 x 109/L;.

9. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 - Mayo Clinic

   - Hemoglobin less than 10 g/dL; - Total bilirubin greater than ULN (upper limit of normal) for the lab or greater than 1.5 x ULN for patients who have a ...

10. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

    - Hemoglobin ≥ the lower limit of normal (LLN) or 9g/dL. - Platelets ≥ 100,000/mm^3. - Serum creatinine ≤ 1.0 x upper limit normal (ULN), or calculated ...